Patents by Inventor Ronald Erwin Boch

Ronald Erwin Boch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle
    Patent number: 10736865
    Abstract: Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle are described as retinoid replacement therapies for treating retinal degenerations in humans.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: August 11, 2020
    Assignee: RETINAGENIX THERAPEUTICS, INC.
    Inventor: Ronald Erwin Boch
  • PHARMACEUTICAL FORMULATIONS COMPRISING 9-CIS-RETINYL ESTERS IN A LIPID VEHICLE
    Publication number: 20190183835
    Abstract: Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle are described as retinoid replacement therapies for treating retinal degenerations in humans.
    Type: Application
    Filed: October 12, 2018
    Publication date: June 20, 2019
    Inventor: Ronald Erwin Boch
  • Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle
    Patent number: 10130606
    Abstract: Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle are described as retinoid replacement therapies for treating retinal degenerations in humans.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: November 20, 2018
    Assignee: NOVELION THERAPEUTICS INC.
    Inventor: Ronald Erwin Boch
  • Compositions and methods for treating influenza
    Patent number: 9610248
    Abstract: The present disclosure provides compositions and methods useful for treating influenza. As described herein, provided compositions and methods are based on the development of certain compositions that include an influenza virus hemagglutinin antigen in combination with lipid vesicles that include a non-ionic surfactant (NISVs) and optionally an adjuvant. In certain embodiments, provided compositions remain potent even when they are not stored in a standard cold-chain system (i.e., they are thermostable).
    Type: Grant
    Filed: July 6, 2011
    Date of Patent: April 4, 2017
    Assignee: Variation Biotechnologies, Inc.
    Inventors: David E. Anderson, Andrei Ogrel, Ronald Erwin Boch, Jeff Baxter
  • PHARMACEUTICAL FORMULATIONS COMPRISING 9-CIS-RETINYL ESTERS IN A LIPID VEHICLE
    Publication number: 20170007565
    Abstract: Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle are described as retinoid replacement therapies for treating retinal degenerations in humans.
    Type: Application
    Filed: September 23, 2016
    Publication date: January 12, 2017
    Inventor: Ronald Erwin Boch
  • Drug delivery system for hydrophobic drugs
    Patent number: 8852629
    Abstract: Compositions comprising microaggregates containing hydrophobic drugs, as well as methods for their production, are described. Such microaggregates may include micelle structures or combinations thereof with liposomes, and constitute an effective delivery vehicle for a hydrophobic agent. Methods for microaggregate production include the use of preferred lipid compounds and processing conditions favoring the production of small aggregates for improved filter sterilization.
    Type: Grant
    Filed: June 19, 2009
    Date of Patent: October 7, 2014
    Assignee: Valeant Pharmaceuticals International, Inc.
    Inventors: Ronald Erwin Boch, Dev Mitra Ranji Singh, Iman Karmadi
  • COMPOSITIONS AND METHODS FOR TREATING INFLUENZA
    Publication number: 20130108692
    Abstract: The present disclosure provides compositions and methods useful for treating influenza. As described herein, provided compositions and methods are based on the development of certain compositions that include an influenza virus hemagglutinin antigen in combination with lipid vesicles that include a non-ionic surfactant (NISVs) and optionally an adjuvant. In certain embodiments, provided compositions remain potent even when they are not stored in a standard cold-chain system (i.e., they are thermostable).
    Type: Application
    Filed: July 6, 2011
    Publication date: May 2, 2013
    Applicant: VARIATION BIOTECHNOLOGIES, INC.
    Inventors: David E. Anderson, Andrei Ogrel, Ronald Erwin Boch, Jeff Baxter
  • PHARMACEUTICAL FORMULATIONS COMPRISING 9-CIS-RETINYL ESTERS IN A LIPID VEHICLE
    Publication number: 20120178806
    Abstract: Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle are described as retinoid replacement therapies for treating retinal degenerations in humans.
    Type: Application
    Filed: September 30, 2009
    Publication date: July 12, 2012
    Applicant: QLT INC.
    Inventor: Ronald Erwin Boch
  • DRUG DELIVERY SYSTEM FOR HYDROPHOBIC DRUGS
    Publication number: 20100247447
    Abstract: Compositions comprising microaggregates containing hydrophobic drugs, as well as methods for their production, are described. Such microaggregates may include micelle structures or combinations thereof with liposomes, and constitute an effective delivery vehicle for a hydrophobic agent. Methods for microaggregate production include the use of preferred lipid compounds and processing conditions favoring the production of small aggregates for improved filter sterilization.
    Type: Application
    Filed: June 19, 2009
    Publication date: September 30, 2010
    Inventors: Ronald Erwin Boch, Dev Mitra Ranji Singh, Iman Karmadi
  • METHODS OF TREATING DERMATOLOGICAL DISORDERS OR CONDITIONS
    Publication number: 20100204317
    Abstract: This invention is directed to the use of TOFA in the treatment of acne and other dermatological disorders. This invention is also directed to pharmaceutical compositions comprising TOFA and a pharmaceutically acceptable excipient for dermatological or oral administration.
    Type: Application
    Filed: November 2, 2007
    Publication date: August 12, 2010
    Applicant: QLT INC.
    Inventors: David W.C. Hunt, Jerome Arthur Morris, Huijun Jiang, Danny Leung, Ronald Erwin Boch
  • Compositions for Treatment of Diseases of the Nail Unit
    Publication number: 20080299165
    Abstract: A flowable composition suitable for use as a controlled release implant, the composition comprising a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid; a biocompatible polar aprotic solvent selected from the group consisting of an amide, an ester, a carbonate, a ketone, an ether, and a sulfonyl; wherein the biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid, and antifungal active.
    Type: Application
    Filed: February 17, 2006
    Publication date: December 4, 2008
    Inventors: Jing-song Tao, Ronald Erwin Boch, Alain H. Curaudeau, Peter Lutwyche, Agnes How-Ching Chan
  • Photodynamic therapy for the treatment of hair loss
    Patent number: 7264629
    Abstract: Photodynamic therapy (PDT) is used to stimulate and/or restore hair growth in areas of hair loss. Methods and compositions relating to PDT treatment for alopecia are disclosed. In light of PDT use to remove unwanted hair by inactivating or destroying hair follicles or destroying the tissue feeding the hair follicles, such methods and compositions relate to a surprising and unexpected discovery. PDT permits a means to treat conditions relating to hair loss such as androgenic alopecia, alopecia areata and drug-induced alopecia.
    Type: Grant
    Filed: April 23, 2003
    Date of Patent: September 4, 2007
    Assignee: QLT, Inc.
    Inventors: Guillermo O. Simkin, Anna M. Richter, David W. C. Hunt, John Robert North, Peter Lutwyche, Ronald Erwin Boch, Jean-Marie Houle
  • Photodynamic therapy for the treatment of hair loss
    Patent number: 7090691
    Abstract: Photodynamic therapy (PDT) is used to stimulate and/or restore hair growth in areas of hair loss. Methods and compositions relating to PDT treatment for alopecia are disclosed. In light of PDT use to remove unwanted hair by inactivating or destroying hair follicles or destroying the tissue feeding the hair follicles, such methods and compositions relate to a surprising and unexpected discovery. PDT permits a means to treat conditions relating to hair loss such as androgenic alopecia, alopecia areata and drug-induced alopecia.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: August 15, 2006
    Assignee: QLT Inc.
    Inventors: Guillermo O. Simkin, Anna M. Richter, David W. C. Hunt, John Robert North, Peter Lutwyche, Ronald Erwin Boch
  • Drug delivery system for hydrophobic drugs
    Patent number: 6984395
    Abstract: Compositions comprising microaggregates containing hydrophobic drugs, as well as methods for their production, are described. Such microaggregates may include micelle structures or combinations thereof with liposomes, and constitute an effective delivery vehicle for a hydrophobic agent. Methods for microaggregate production include the use of preferred lipid compounds and processing conditions favoring the production of small aggregates for improved filter sterilization.
    Type: Grant
    Filed: April 11, 2001
    Date of Patent: January 10, 2006
    Assignee: QLT, Inc.
    Inventors: Ronald Erwin Boch, Dev Mitra Ranji Singh, Iman Karmadi
  • Photodynamic therapy for the treatment of hair loss
    Publication number: 20040029856
    Abstract: Photodynamic therapy (PDT) is used to stimulate and/or restore hair growth in areas of hair loss. Methods and compositions relating to PDT treatment for alopecia are disclosed. In light of PDT use to remove unwanted hair by inactivating or destroying hair follicles or destroying the tissue feeding the hair follicles, such methods and compositions relate to a surprising and unexpected discovery. PDT permits a means to treat conditions relating to hair loss such as androgenic alopecia, alopecia areata and drug-induced alopecia.
    Type: Application
    Filed: April 23, 2003
    Publication date: February 12, 2004
    Inventors: Guillermo O. Simkin, Anna M. Richter, David W. C. Hunt, John Robert North, Peter Lutwyche, Ronald Erwin Boch, Jean-Marie Houle
  • Photodynamic therapy for the treatment of hair loss
    Publication number: 20040015214
    Abstract: Photodynamic therapy (PDT) is used to stimulate and/or restore hair growth in areas of hair loss. Methods and compositions relating to PDT treatment for alopecia are disclosed. In light of PDT use to remove unwanted hair by inactivating or destroying hair follicles or destroying the tissue feeding the hair follicles, such methods and compositions relate to a surprising and unexpected discovery. PDT permits a means to treat conditions relating to hair loss such as androgenic alopecia, alopecia areata and drug-induced alopecia.
    Type: Application
    Filed: November 8, 2002
    Publication date: January 22, 2004
    Inventors: Guillermo O. Simkin, Anna M. Richter, David W. C. Hunt, John Robert North, Peter Lutwyche, Ronald Erwin Boch
  • Drug delivery system for hydrophobic drugs
    Publication number: 20020156062
    Abstract: Compositions comprising microaggregates containing hydrophobic drugs, as well as methods for their production, are described. Such microaggregates may include micelle structures or combinations thereof with liposomes, and constitute an effective delivery vehicle for a hydrophobic agent. Methods for microaggregate production include the use of preferred lipid compounds and processing conditions favoring the production of small aggregates for improved filter sterilization.
    Type: Application
    Filed: April 11, 2001
    Publication date: October 24, 2002
    Inventors: Ronald Erwin Boch, Dev Mitra Ranji Singh, Iman Karmadi